Cargando…
Endo180 at the cutting edge of bone cancer treatment and beyond
Skeletal bone is an attractive site for secondary tumour growth and is also home to spontaneous primary cancer. Treatment of bone metastasis is focused on limiting the vicious cycle of bone destruction with bisphosphonates or inhibition of receptor activator of nuclear factor‐κB ligand (RANKL) with...
Autor principal: | Sturge, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819699/ https://www.ncbi.nlm.nih.gov/pubmed/26576691 http://dx.doi.org/10.1002/path.4673 |
Ejemplares similares
-
GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis
por: Sturge, Justin, et al.
Publicado: (2003) -
Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer
por: Palmieri, C, et al.
Publicado: (2013) -
Endosomes generate localized Rho–ROCK–MLC2–based contractile signals via Endo180 to promote adhesion disassembly
por: Sturge, Justin, et al.
Publicado: (2006) -
Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces
por: Caley, Matthew P., et al.
Publicado: (2015) -
Commentary: Strength at the cutting edge
por: Wan, Song, et al.
Publicado: (2020)